NCT07378306 2026-04-21
FACT-TN
Sun Yat-sen University
Phase 2 Recruiting
Clinical Trials
6 trialsNCT07540533 2026-04-20
2025-370
Henan Cancer Hospital
Phase 2 Recruiting
NCT07457359 2026-03-09
NEOTRIO-2
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07410234 2026-02-13
Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07281976 2026-02-12
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Recruiting
NCT07383818 2026-02-03
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting